Buy rating on Thermax; No pick-up yet in order flow

Investor expectation of superior performance backs stock

Operating performance in-line; intake remains constrained: Thermax (TMX) reported in-line operating performance for Q1FY16. Revenue grew 19% year-on-year to Rs 10 bn, Ebitda (earnings before interest taxes depreciation and amortisation) margin expanded 221 basis point y-o-y to 9.1%, and net profit grew 49% y-o-y to Rs 617 mn. Consolidated revenue grew 23.9% y-o-y to Rs 12.5 bn; net profit grew 234% y-o-y to Rs 578 mn.

The Energy segment reported 25% y-o-y revenue growth, led by execution of the Reliance order. The Environment business reported revenue decline of 1.8% y-o-y, impacted by constrained intake in the Water segment. Ebit margin in the Energy business expanded 440 bp y-o-y to 11%. Environment segment Ebit margin expanded 190bp y-o-y to 6.4%, largely supported by base effect. Energy segment margins were impacted, as the Reliance project had not crossed the margin recognition threshold; Environment segment margins were impacted by losses in water projects in Q1FY15.

Subsidiary losses narrowed to just Rs 39m, the lowest since Q3FY14. This shows losses on European business have been curtailed and that execution has possibly improved in the Thermax-Babcock JV (received orders of R6 bn + from Babcock & Wilcox overseas wins).


Standalone order inflow in Q1FY16 was just R9 bn. Domestic intake has remained constrained at just R7 bn-8 bn in the last six-seven quarters, reflecting that activity on the ground is yet to pick up. The order book has shrunk 18% y-o-y.

Cost analysis for Q1 indicates that RM (raw material) costs stand at 63.4% (up 190 bps y-o-y); Other expenses at 16.4% are down 300 bps y-o-y.

Subsidiary losses have narrowed to just Rs 39 mn, and is the lowest run-rate since Q3FY14. These clearly indicate that losses pertaining to European business have been curtailed; and also possibly improved execution in Thermax-Babcock JV (received orders of Rs 6 bn+ from Babcock & Wilcox overseas wins).


Consolidated revenues stood at Rs 12.5 bn (up 23.9% y-o-y) and profits at Rs 578m (up 234% y-o-y).

Maintain Buy; core portfolio holding: Strong commitment to the core ‘strategy’ and the journey till date has improved the investor perception about ‘sustainable superior performance’ and hence the stock’s premium valuations. Maintain Buy with a 12-month price target of Rs 1,275 (30x FY17e at Rs 1,117/share and Rs 141/share for subsidiaries). Premium valuations are supported by: (i) expectations of strong 43% earnings CAGR (compound annual growth rate) over the next five years, (ii) robust FY15 RoCE (return on capital employed) at 16.3% (in a down-cycle), (iii) FY15 net working capital at just eight days (reflecting the bargaining power of the business); and (iv) net cash at Rs 6.2 bn (up from Rs 4.2 bn in FY14).


Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express Telegram Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.